SARS-CoV-2 Mpro-IN-19

• UNSPSC Description:

  SARS-CoV-2 Mpro-IN-19 (compound MPI94) is a SARS-CoV-2 MPro inhibitor with the IC50 of 0.096 μM. SARS-CoV-2 Mpro-IN-19 can be used for study of COVID-19[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-mpro-in-19.html

• Smiles:

  O=C(N1[C@H](C(N[C@@H](C[C@H]2C(NCC2)=O)C=O)=O)[C@@]3([H])C(C)(C)[C@@]3([H])C1)OC(C4=CC=CC=C4)C5=CC=CC=C5

• Molecular Weight:

  503.59

• References & Citations:

  [1]Lauren R. Blankenship, et al. SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme. ACS Med. Chem. Lett. 2024, 15, 6, 950–957.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported